Scientific Committee

Keynote Speaker

Philip Helliwell, PhD DM FRCP
Senior Lecturer
University of Leeds, United Kingdom
View Biography

Guest Speakers

Local Speakers

Vinod Chandran, MB BS MD
View Biography

Lihi Eder, MD, PhD
View Biography

Faculty Disclosure

It is the policy of University of Toronto, Faculty of Medicine, Continuing Professional Development to ensure balance, independence, objectivity, and scientific rigor in all its individually accredited or jointly accredited educational programs. Speakers and/or planning committee members, participating in University of Toronto accredited programs, are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships within the last FIVE (5) years with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of facts. It remains for the audience to determine whether the speaker's outside interests may reflect a possible bias in either the exposition or the conclusions presented.

Faculty Disclosure Statements

The following speakers and planning committee members have disclosed the following:

Drs. Vinod Chandran, Lihi Eder, James T. Elder, Vern Farewell, Dafna Gladman, Philip Helliwell, Proton Rahman and Carter Thorne have/had no financial interest/arrangement or affiliation with one or more organizations that could be perceived as a related or apparent conflict of interest in the context of the subject of their presentation.

The following have declared financial interests, arrangements or affiliations with one or more organizations that could be perceived as a related or apparent conflict of interest of the subject of this presentation over the past five (5) years:

Speaker / Committee	Grant / Research Support	Consultant	Speakers’ Bureau	Other Financial / Material Support
Wolf-Henning Boehncke	Janssen - role of TH17 cell cytokines in endothelial dysfunction; Wyeth - biomarkers for metabolic and cardiovascular comorbidities	Abbot, Biogen Idec, Janssen, Lilly, MSD, Novartis, Pfizer	Abbot, Biogen Idec, Janssen, MSD, Pfizer
Joel Gelfand	NIH (NIAMS and NHLBI), Abbrie, Amgen, Novartis, Lilly	Amgen, Novartis, Abbvie, Janssen, Lilly, Pfizer, Merck
Alice Gottlieb	Via Tufts: Centocor (Janssen), Amgen, Abbot, Novartiz, Celgene, Pfizer, Lilly	Amgen, Astellas, Centocor (Janssen), Celgene, Bristol Myers Squibb, Beiersdorf, Abbvie, TEVA, Actelion, UCB, Novo Nordisk, Novartis, Dermipsor, Incyte, Pfizer, Canfite, Lilly, Coronado, Vertex, Karyopharm
Philip Mease	AbbVie, Amgen, Biogen Idec, Bristol Myers Squibb, Celgene, Crescendo, Genentech, Janssen, Lilly, Merck, Novartis, Pfizer, and UCB	AbbVie, Amgen, Biogen Idec, Bristol Myers Squibb, Celgene, Crescendo, Genentech, Janssen, Lilly, Merck, Novartis, Pfizer, and UCB	AbbVie, Amgen, Biogen Idec, Bristol Myers Squibb, Crescendo, Genentech, Janssen, Lilly, Pfizer, UCB
Christopher Ritchlin	Amgen, Pfizer, Janssen, UCB	Abbvie, Amjen, Janssen, Pfizer, Lilly, UCB
Cheryl Rosen	Abbott, AbbVie Labs	Amgen Inc., Centocor, Johnson & Johnson, AbbVie Labs, Leo Pharma		AbbVie Labs, Amgen Inc., Johnson & Johnson, Leo Pharma